Ledger.Open graph →
SEC Form D · filed May 6, 2024

C2N Diagnostics, LLC

Offering
$15.0M
Sold
$7.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ST. LOUIS, MO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Micah Onixt · St. Louis, MOExecDr. Joel Braunstein · St. Louis, MOExec · DirectorDr. Randall Bateman · St. Louis, MODirectorDr. Michael Goldblatt · St. Louis, MODirectorDr. David Holtzman · St. Louis, MODirectorMicah Onixt · St. Louis, MOExecDr. Joel Braunstein · St. Louis, MOExec · DirectorDr. Randall Bateman · St. Louis, MODirectorDr. Michael Goldblatt · St. Louis, MODirectorDr. David Holtzman · St. Louis, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗